Type IV hypersensitivity disease
MONDO:0002459A disease that has its basis in the disruption of type IV hypersensitivity.
Also known as: DTH, delayed hypersensitivity reaction, delayed-type hypersensitivity, delayed-type hypersensitivity response, disorder of type IV hypersensitivity, type 4 hypersensitivity reaction, type IV hypersensitivity, type IV hypersensitivity reaction
20 clinical trials for this condition and its sub-types, 0 tagged with Type IV hypersensitivity disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Type IV hypersensitivity disease
-
Autoimmune lymphoproliferative syndrome 11 trials · 12 incl. sub-types
9 sub-types
- Autoimmune lymphoproliferative syndrome type 4 3 trials
- FAS-related autoimmune lymphoproliferative syndrome 2 trials
- Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 1 trial
- Castleman-Kojima disease 0 trials
- Autoimmune lymphoproliferative syndrome type 1 0 trials
- Autoimmune lymphoproliferative syndrome type 2A 0 trials
- Autoimmune lymphoproliferative syndrome type 2B 0 trials
- Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD 0 trials
- Type 3 autoimmune lymphoproliferative syndrome 0 trials
-
Cryoglobulinemia 3 trials
1 sub-type
- Cryofibrinogenemia 0 trials Sub-types →
-
Serum sickness 3 trials
Most studied deeper sub-types
-
Needle-Free epinephrine film could transform emergency allergy care for kids
Disease control CompletedThis study tests a new dissolving film called DESF that delivers epinephrine under the tongue. It is designed for children ages 7 to 17 who weigh at least 30 kg and have a history of allergic reactions that put them at high risk for severe episodes like anaphylaxis. The goal is t…
Phase 1 • Sponsor: Aquestive Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Experimental IL-2 treatment shows promise for Hard-to-Treat HCV vasculitis
Disease control CompletedThis study tested a drug called interleukin-2 (IL-2) in 10 people with hepatitis C-related vasculitis that did not get better with usual treatments. The goal was to see if IL-2 could boost the body's immune regulation and control the disease. Participants received IL-2 injections…
Phase 1/2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused CompletedThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Vitamin d levels checked for clues to heart risk in kidney patients
Knowledge-focused CompletedThis study looked at whether vitamin D levels in the blood are related to early signs of artery hardening (atherosclerosis) in people on dialysis. Researchers measured vitamin D and used ultrasound to check artery thickness in 90 adults with kidney failure. The goal was to see if…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Hospital staff antibody study tracks COVID-19 immunity over a year
Knowledge-focused CompletedThis study looked at how many hospital workers had COVID-19 antibodies and how long they lasted. Over 500 staff at a French cancer center gave blood samples and answered questionnaires at the start, 3 months, and 12 months. The goal was to understand immune response in people who…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:35 UTC